|
Issue |
Title |
|
Vol 2, No 3 (2020): Aging Pathobiology and Therapeutics |
Short-term oral rapamycin prevents age-related learning impairment in mice |
Abstract
PDF
HTML
|
Haoyi Lei, Juan Wang, Warren Ladiges, Zhou Jiang |
|
Vol 1, No 1 (2019): Aging Pathobiology and Therapeutics |
Sleep-deprived cognitive impairment in aging mice is alleviated by rapamycin |
Abstract
PDF
HTML
|
Kishore Mukherjee, Amanda Lee, Lida Zhu, Martin Darvas, Warren Ladiges |
|
Vol 4, No 2 (2022): Aging Pathobiology and Therapeutics |
Sotrovimab for treatment of COVID-19 infections |
Abstract
PDF
HTML
|
Shyh Poh Teo |
|
Vol 2, No 4 (2020): Aging Pathobiology and Therapeutics |
Spontaneous chordoma: a case report on a female UM-HET3 mouse from the SLAM study |
Abstract
PDF
HTML
|
Eleonora Duregon, Camila Vieira Ligo Teixeira, Dushani L. Palliyaguru, Annamaria L. Rudderow, Victoria Hoffmann, Michel Bernier, Nathan L. Price, Simonetta Camandola, Rafael de Cabo |
|
Vol 5, No 4 (2023): Aging Pathobiology and Therapeutics |
Statins adherence and associated muscle symptoms in elderly coronary heart disease patients |
Abstract
PDF
HTML
|
Marina G. Bubnovaa, Marat V Ezhov, David M. Aronov |
|
Research advances on cellular senescence and cancer (Ongoing) |
Targeted regulation of senescence-associated secretory phenotype with an aptamer-conjugated activatable senomorphic |
Abstract
PDF
HTML
|
Yuqi Xie, Jili Li, Pingyu Wu, Linlin Wang, Donghui Hong, Jian Wang, Yanlan Liu |
|
Research advances on cellular senescence and cancer (Ongoing) |
Targeted regulation of senescence-associated secretory phenotype with an aptamer-conjugated activatable senomorphic |
Abstract
PDF
HTML
|
Yuqi Xie, Jili Li, Pingyu Wu, Linlin Wang, Donghui Hong, Jian Wang, Yanlan Liu |
|
Vol 4, No 4 (2022): Aging Pathobiology and Therapeutics |
Targeting IGF1R signaling for brain aging and Alzheimer’s disease |
Abstract
PDF
HTML
|
Joo Young Park, Martin Darvas, Warren Ladiges |
|
Vol 4, No 3 (2022): Aging Pathobiology and Therapeutics |
Targeting metabolism through exercise and nutrition to rejuvenate an aging immune system |
Abstract
PDF
HTML
|
Brandt D. Pence |
|
Vol 3, No 4 (2021): Aging Pathobiology and Therapeutics |
The aging immune system. Abstracts presented at the Masoro-Barshop conference on aging, October 13-15, 2021 |
Abstract
PDF
HTML
|
Warren Ladiges |
|
Vol 3, No 2 (2021): Aging Pathobiology and Therapeutics |
The antidiabetic drug acarbose suppresses age-related lesions in C57BL/6 mice in an organ dependent manner |
Abstract
PDF
HTML
|
Sneh Gupta, Zhou Jiang, Warren Ladiges |
|
Vol 5, No 2 (2023): Aging Pathobiology and Therapeutics |
The case of a geriatric female experiencing frequent falls and epileptic seizures during long-term low-dose clozapine and extended-release bupropion treatment |
Abstract
PDF
HTML
|
Charisse Dzierba, Claudia Lee, Tammie Lee Demler |
|
Vol 5, No 1 (2023): Aging Pathobiology and Therapeutics |
The CB6F1 mouse is a model for studying cognition and brain morphometry with increasing age |
Abstract
PDF
HTML
|
Davika Gandhay, Christina Pettan Brewer, Warren Ladiges |
|
Vol 2, No 3 (2020): Aging Pathobiology and Therapeutics |
The cellular senescence unification model and telomerase therapy: To treat all age-related diseases |
Abstract
PDF
HTML
|
Steve Liebich |
|
Vol 4, No 3 (2022): Aging Pathobiology and Therapeutics |
The critical role of macrophages in ovarian cancer treatment |
Abstract
PDF
HTML
|
Yiran Wang, Mingyi Wang |
|
Vol 4, No 4 (2022): Aging Pathobiology and Therapeutics |
The Eph receptor A4-mediated demyelination in depression |
Abstract
PDF
HTML
|
Luodan Yang, Quanguang Zhang |
|
Vol 6, No 1 (2024): Aging Pathobiology and Therapeutics |
The house cricket is an unrecognized but potentially powerful model for aging intervention studies |
Abstract
PDF
HTML
|
Gerald Yu Liao, Manuela Rosenfeld, Jackson Wezeman, Warren Ladiges |
|
Vol 2, No 1 (2020): Aging Pathobiology and Therapeutics |
The potential of GHK as an anti-aging peptide |
Abstract
PDF
HTML
|
Yan Dou, Amanda Lee, Lida Zhu, John Morton, Warren Ladiges |
|
Vol 2, No 2 (2020): Aging Pathobiology and Therapeutics |
The potential of XPO1 inhibitors as a game changer in relapsed/refractory hematologic malignancies |
Abstract
PDF
HTML
|
Henan Wang, Jing Yang, Liang Wang |
|
Vol 1, No 1 (2019): Aging Pathobiology and Therapeutics |
The rationale for testing drug combinations in aging intervention studies |
Abstract
PDF
HTML
|
Kavita C Sharma, Juan Wang, Zhou Jiang, Jenna Klug, Martin Darvas, Denise M Imai, Timothy Snider, Laura Niedernhofer, Warren C Ladiges |
|
Aging and Cardiovascular Diseases (Ongoing) |
The role of immune aging in giant cell arteritis |
Abstract
PDF
HTML
|
Patricia Harkins, Sharon Cowley, Robert Harrington, David Kane, Richard Conway |
|
Aging and Cardiovascular Diseases (Ongoing) |
The role of immune aging in giant cell arteritis |
Abstract
PDF
HTML
|
Patricia Harkins, Sharon Cowley, Robert Harrington, David Kane, Richard Conway |
|
Vol 3, No 4 (2021): Aging Pathobiology and Therapeutics |
The unrecognized potential of pet cats for studying aging and age-related diseases |
Abstract
PDF
HTML
|
Warren Ladiges |
|
Vol 2, No 3 (2020): Aging Pathobiology and Therapeutics |
Thioredoxin and aging: What have we learned from the survival studies? |
Abstract
PDF
HTML
|
Madeline G. Roman, Lisa C. Flores, Geneva M. Cunningham, Christie Cheng, Colton Allen, Gene Borden Hubbard, Yidong Bai, Thomas L. Saunders, Yuji Ikeno |
|
Vol 2, No 4 (2020): Aging Pathobiology and Therapeutics |
Thioredoxin down-regulation in the cytosol in thioredoxin 2 transgenic mice did not have beneficial effects to extend lifespan in male C57BL/6 mice |
Abstract
PDF
HTML
|
Madeline G. Roman, Lisa C. Flores, Geneva M. Cunningham, Christie Cheng, Colton Allen, Yidong Bai, Gene B. Hubbard, Yuji Ikeno |
|
126 - 150 of 155 Items |
<< < 1 2 3 4 5 6 7 > >> |